Versa Vascular
Versa Vascular

Versa Vascular

DR17Ahrefs DR: 17/100. Bottom 25%. Measured by Ahrefs. Median 44.eDR55Effective DR: 55/100. Below median. Measured by StartupHub.ai. Median 68.Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Speed91Site Speed: 91/100. Top 25%. Measured by Google PageSpeed. Median 62.

Developing innovative, minimally invasive solutions for tricuspid valve disease treatment.

Website
2017ActiveSanta Cruz, United States

About

Versa Vascular is developing a novel, minimally invasive tricuspid valve repair solution to improve the lives of patients with clinically relevant tricuspid regurgitation. Their implant is designed for stable, precise placement entirely within the right atrium, supporting native leaflet function to improve blood flow. The company focuses on creating clinically oriented, collaborative solutions for unmet patient needs in structural heart disease.

Key facts

At-a-glance profile data

Website
versavascular.com
Headquarters
Santa Cruz, United States
Founded
2017
Total funding
$15M (Series C)
Business model
B2B

Funding rounds

Funding rounds raised by Versa Vascular
DateRoundAmountLead investors
11 Aug 2026Series C$15M-

Tech stack

Detected on versavascular.com, last scanned 15 Sept 2026. Run your own scan

Frontend
jQuery
SEO
Yoast SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Microsoft 365
Add first review

Frequently asked

Is Versa Vascular trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Versa Vascular is 52 out of 100, based on site security posture and privacy practices.

How much funding has Versa Vascular raised?

Versa Vascular has raised a total of $15M in funding. The most recent round on record is Series C.